Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Buy
58
EXPO Quote, Financials, Valuation and Earnings
Last price:
$71.84
Seasonality move
:
5.64%
Day range:
$71.52 - $72.60
52-week range:
$63.81 - $97.57
Dividend yield:
1.67%
P/E ratio:
35.25x
P/S ratio:
6.47x
P/B ratio:
8.89x
Volume:
181.2K
Avg. volume:
441.9K
1-year change:
-20.65%
Market cap:
$3.6B
Revenue:
$558.5M
EPS (TTM):
$2.04
Analysts' Opinion
-
Consensus RatingExponent, Inc. has received a consensus rating of Buy. The company's average rating is a Buy based on 2 Buy ratings, 1 Hold rating, and 0 Sell ratings.
-
Price Target UpsideAccording to analysts' consensus price target of $85.50, Exponent, Inc. has an estimated upside of 19.13% from its current price of $71.77.
-
Price Target DownsideAccording to analysts, the lowest downside price target is $81.00 representing 100% downside risk from its current price of $71.77.
Fair Value
-
According to the consensus of 3 analysts, Exponent, Inc. has 19.13% upside to fair value with a price target of $85.50 per share.
EXPO vs. S&P 500
-
Over the past 5 trading days, Exponent, Inc. has underperformed the S&P 500 by -3.98% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Exponent, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Exponent, Inc. has grown year-over-year revenues for 7 quarters straight. In the most recent quarter Exponent, Inc. reported revenues of $147.1M.
Earnings Growth
-
Exponent, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Exponent, Inc. reported earnings per share of $0.55.
Enterprise value:
3.5B
EV / Invested capital:
7.12x
Price / LTM sales:
6.47x
EV / EBIT:
29.31x
EV / Revenue:
6.05x
PEG ratio (5yr expected):
9.50x
EV / Free cash flow:
28.12x
Price / Operating cash flow:
30.07x
Enterprise value / EBITDA:
27.01x
Gross Profit (TTM):
$142.4M
Return On Assets:
13.66%
Net Income Margin (TTM):
18.35%
Return On Equity:
24.92%
Return On Invested Capital:
20.89%
Operating Margin:
19.74%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Income Statement | ||||||
| Revenue | $541.2M | $544.6M | $571.4M | $136.3M | $147.1M | |
| Gross Profit | $140.4M | $133.6M | $142.4M | $31.2M | $36.7M | |
| Operating Income | $115M | $110.7M | $117.9M | $25.8M | $29M | |
| EBITDA | $123.4M | $120.3M | $127.9M | $28.2M | $31.6M | |
| Diluted EPS | $1.97 | $2.06 | $2.04 | $0.50 | $0.55 | |
| Period Ending | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2025-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $417.6M | $332.5M | $343.3M | $412.6M | $416.8M | |
| Total Assets | $638.3M | $559M | $602.5M | $744.1M | $761.4M | |
| Current Liabilities | $126.4M | $137.9M | $129.7M | $137.7M | $154.8M | |
| Total Liabilities | $233.3M | $239.2M | $248.8M | $333.8M | $358.6M | |
| Total Equity | $405M | $319.8M | $353.6M | $410.3M | $402.9M | |
| Total Debt | $10.7M | $13.2M | $22M | $75.9M | $76.1M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-09-30 | 2024-09-30 | 2025-09-30 | 2024-09-30 | 2025-09-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $96.6M | $159.8M | $132.2M | $29.7M | $32.7M | |
| Cash From Investing | -$17.4M | -$6.3M | -$9.3M | -$1.7M | -$2.7M | |
| Cash From Financing | -$91.4M | -$72.8M | -$134.3M | -$13M | -$54.5M | |
| Free Cash Flow | $79.3M | $153.5M | $122.9M | $28M | $30M | |
EXPO
Sector
Market Cap
$3.6B
$486.6M
Price % of 52-Week High
73.56%
80.87%
Dividend Yield
1.67%
0%
Shareholder Yield
3.63%
1.54%
1-Year Price Total Return
-20.65%
--
Beta (5-Year)
0.819
0.550
Dividend yield:
1.67%
Annualized payout:
$1.12
Payout ratio:
54.75%
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$73.08
200-day SMA
Sell
Level
$73.65
Bollinger Bands (100)
Buy
Level
68.19 - 72.49
Chaikin Money Flow
Buy
Level
82.1M
20-day SMA
Sell
Level
$72.92
Relative Strength Index (RSI14)
Sell
Level
48.02
ADX Line
Buy
Level
22.67
Williams %R
Neutral
Level
-76.4801
50-day SMA
Buy
Level
$70.90
MACD (12, 26)
Buy
Level
0.45
25-day Aroon Oscillator
Buy
Level
64
On Balance Volume
Neutral
Level
90.9M
Financial Scores
Buy
Altman Z-Score
(Annual)
Level (9.6752)
Buy
CA Score
(Annual)
Level (0.695)
Buy
Beneish M-Score
(Annual)
Level (-2.7022)
Sell
Momentum Score
Level (2)
Buy
Ohlson Score
Level (-0.982)
Buy
Piotroski F Score
(Annual)
Level (6)
Buy
Quality Ratio Score
Level (6)
Buy
Fundamental Score
Level (10)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Exponent, Inc. is an engineering and scientific consulting company, which provides engineering, scientific, environmental, and health consulting services. It operates through the Engineering and Other Scientific, and Environmental and Health segments. The Engineering and Other Scientific segment includes technical consulting in different practices primarily in engineering. The Environmental and Health segment offers services in environmental, epidemiology, and health risk analysis. The company was founded by Bernard Ross in 1967 and is headquartered in Menlo Park, CA.
Stock Forecast FAQ
In the current month, EXPO has received 2 Buy ratings 1 Hold ratings, and 0 Sell ratings. The EXPO average analyst price target in the past 3 months is $85.50.
-
Where Will Exponent, Inc. Stock Be In 1 Year?
According to analysts, the consensus estimate is that Exponent, Inc. share price will rise to $85.50 per share over the next 12 months.
-
What Do Analysts Say About Exponent, Inc.?
Analysts are divided on their view about Exponent, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Exponent, Inc. is a Sell and believe this share price will drop from its current level to $81.00.
-
What Is Exponent, Inc.'s Price Target?
The price target for Exponent, Inc. over the next 1-year time period is forecast to be $85.50 according to 3 Wall Street analysts, 2 of them rate the stock a Buy, 0 rate the stock a Sell, and 1 analyst rates the stock a Hold.
-
Is EXPO A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Exponent, Inc. is a Buy. 2 of 3 analysts rate the stock a Buy at this time.
-
How Can I Buy Shares Of EXPO?
You can purchase shares of Exponent, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Exponent, Inc. shares.
-
What Is The Exponent, Inc. Share Price Today?
Exponent, Inc. was last trading at $71.84 per share. This represents the most recent stock quote for Exponent, Inc.. Yesterday, Exponent, Inc. closed at $71.77 per share.
-
How To Buy Exponent, Inc. Stock Online?
In order to purchase Exponent, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Get EXPO Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
EXPO
Sector
P/E ratio
35.25x
19.19x
PEG ratio
9.50x
0.18x
P/B ratio
8.89x
1.70x
Price / LTM sales
6.47x
0.85x
Growth Metrics
EXPO
Sector
Revenue growth
7.96%
5.02%
Earnings growth
8.62%
5.76%
Revenue (5-year growth)
6.01%
4.27%
Earnings forecast
$0.53
$0.39
Profitability
EXPO
Sector
Profitability FY 2024
$142.3M
$253.7M
Return on invested capital
20.89%
4.73%
Return on assets
13.66%
3.1%
Return on equity
24.92%
8.11%
Earnings Date
Last Earnings Date
Oct
30
Next Earnings Date
Feb
5
Estimated Next Earnings Date
Jan
29
Balance Sheet
EXPO
Sector
Total cash
$207.4M
$139M
Short term investments
--
$32.7M
Total assets
$809M
$1.4B
Long term debt
$76.1M
$51.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
85
HUT alert for Dec 25
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
80
TVTX alert for Dec 25
Travere Therapeutics, Inc. [TVTX] is up 14.03% over the past day.
Buy
63
GPCR alert for Dec 25
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
